Evidence map›Paper›PMID 36028102›Full record

ArticleDevelopmental biology2022

Deciphering the role of retinoic acid in hepatic patterning and induction in the mouse.

Taylor M Guertin, Amrita Palaria, Jesse Mager, Lisa L Sandell, Paul A Trainor, Kimberly D Tremblay

Open access · greenAbstract read
In one paragraph

Article in Developmental biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Taylor M GuertinDepartment of Veterinary and Animal Sciences, University of Massachusetts, Amherst, MA, USA.
Amrita PalariaDepartment of Veterinary and Animal Sciences, University of Massachusetts, Amherst, MA, USA.
Jesse MagerDepartment of Veterinary and Animal Sciences, University of Massachusetts, Amherst, MA, USA.
Lisa L SandellDepartment of Oral Immunology and Infectious Diseases, School of Dentistry, University of Louisville, Louisville, KY, USA.
Paul A TrainorStowers Institute for Medical Research, Kansas City, MO, USA; Department of Anatomy and Cell Biology, School of Medicine, University of Kansas, Kansas City, KS, USA.
Kimberly D TremblayDepartment of Veterinary and Animal Sciences, University of Massachusetts, Amherst, MA, USA. Electronic address: kdtrembl@umass.edu.
University of Massachusetts Amherst · USStowers Institute for Medical Research · USUniversity of Louisville · US

Funding

Resolving heterogeneity in liver developmentR01DK123363 · NIDDK · UNIVERSITY OF MASSACHUSETTS AMHERST · PI TREMBLAY, KIMBERLY D · 2020 to 2022
$1.1M
NIDDK NIH HHS R01 DK123363
6 · The paper itself

Abstract

Retinoic acid (RA), a metabolite of vitamin A, is a small molecule and morphogen that is required for embryonic development. While normal RA signals are required for hepatic development in a variety of vertebrates, a role for RA during mammalian hepatic specification has yet to be defined. To examine the requirement for RA in murine liver induction, we performed whole embryo culture with the small molecule RA inhibitor, BMS493, to attenuate RA signaling immediately prior to hepatic induction and through liver bud formation. BMS493 treated embryos demonstrated a significant loss of hepatic specification that was confined to the prospective dorsal anterior liver bud. Examination of RA attenuated embryos demonstrates that while the liver bud displays normal expression of foregut endoderm markers and the hepato-pancreatobiliary domain marker, PROX1, the dorsal/anterior liver bud excludes the critical hepatic marker, HNF4α, indicating that RA signals are required for dorsal/anterior hepatic induction. These results were confirmed and extended by careful examination of Rdh10<sup>trex/trex</sup> embryos, which carry a genetic perturbation in RA synthesis. At E9.5 Rdh10<sup>trex/trex</sup> embryos display a similar yet more significant loss of the anterior/dorsal liver bud. Notably the anterior/dorsal liver bud loss correlates with the known dorsal-ventral gradient of the RA synthesis enzyme, Aldh1a2. In addition to altered hepatic specification, the mesoderm surrounding the liver bud is disorganized in RA abrogated embryos. Analysis of E10.5 Rdh10<sup>trex/trex</sup> embryos reveals small livers that appear to lack the dorsal/caudal lobes. Finally, addition of exogenous RA prior to hepatic induction results in a liver bud that has failed to thicken and is largely unspecified. Taken together our ex vivo and in vivo evidence demonstrate that the generation of normal RA gradients is required for hepatic patterning, specification, and growth.

Indexed as

TretinoinVitamin AAnimalsEndodermFemaleLiverMammalsMicePregnancyProspective StudiesTretinoinVitamin A

Identifiers

PMID36028102
PMCPMC11651638
OpenAlexW4292808867

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.